Recent News

• 10.22.2025 - Now is the moment
• 10.01.2025 - GeneDx Announces First U.S. National Genomic Newborn Screening Initiative Launched with $14.4 Million NIH Award
• 09.30.2025 - GeneDx Appoints Lisa Gurry as Chief Business Officer to Unlock Data and Information Growth
• 09.25.2025 - GeneDx Infinity™ Pioneers a New Era of Genetic Medicine with its Introduction at the American Academy of Pediatrics National Conference
• 09.24.2025 - Genetic testing options for children: a comprehensive guide
• 09.22.2025 - Unexplained epilepsy doesn’t have to remain unexplained. Even for adults, answers are within reach.
• 09.18.2025 - GeneDx Appoints Visionary AI and Precision Medicine Leader Dr. Thomas Fuchs to Board of Directors
• 09.15.2025 - A useful tool for back-to-school concerns

Recent Filings

• 10.06.2025 - 4/A Statement of changes in beneficial ownership of securities
• 10.01.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.01.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.30.2025 - 144 Report of proposed sale of securities
• 09.30.2025 - 144 Report of proposed sale of securities
• 09.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.19.2025 - 3 Initial statement of beneficial ownership of securities
• 09.18.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.18.2025 - 8-K Current report
• 09.18.2025 - 4 Statement of changes in beneficial ownership of securities